$93.4MRound, 9 July 2025
Funds CMC development and a Phase 1/2 trial of SRC3-KO planned for H1 2026.
- Amount
- $93.4M
- Announced
- 9 July 2025
- Use of funds
- Funds CMC development and a Phase 1/2 trial of SRC3-KO planned for H1 2026.
- Checked
- Announced by the company
- Sources
- CoRegen raises $93.39M (date approx) biospace.com
CoRegen raises $93.39M (date approx) pulse2.com